Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
07 Novembro 2023 - 9:00AM
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will
report its first quarter fiscal year 2024 financial results on
Tuesday, November 14, 2023, before market open. The Company will
host a corresponding conference call and live webcast to discuss
the financial results and key topics including business strategy,
partnerships and regulatory and reimbursement processes, at 8:30
a.m. (ET) / 1:30 p.m. (GMT).
Conference Call Details:To participate in the
live conference call via telephone, please register here. Upon
registering, a dial-in number and unique PIN will be provided in
order for interested parties to join the conference call.
Webcast Registration
link: https://edge.media-server.com/mmc/p/mdyeh2j3
For further information, please contact:
Renalytix plc |
www.renalytix.com |
James McCullough, CEO |
Via Walbrook PR |
|
|
Stifel (Nominated Adviser, Joint Broker) |
Tel: 020 7710 7600 |
Alex Price / Nicholas Moore / Nick Harland / Samira Essebiyea |
|
|
|
Investec Bank plc (Joint Broker) |
Tel: 020 7597 4000 |
Gary Clarence / Shalin Bhamra |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or
renalytix@walbrookpr.com |
Paul McManus / Alice Woodings |
Mob: 07980 541 893 / 07407 804 654 |
|
|
CapComm Partners |
|
Peter DeNardo |
Tel: 415-389-6400 or investors@renalytix.com |
About RenalytixRenalytix
(NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and
laboratory services company that is the global founder and leader
in the new field of bioprognosis™ for kidney health. The leadership
team, with a combined 200+ years of healthcare and in-vitro
diagnostic experience, has designed its KidneyIntelX laboratory
developed test to enable risk assessment for rapid progressive
decline in kidney function in adult patients with T2D and early CKD
(stages 1-3). We believe that by understanding how disease will
progress, patients and providers can take action early to improve
outcomes and reduce overall health system costs. For more
information, visit www.renalytix.com.
Renalytix (NASDAQ:RNLX)
Gráfico Histórico do Ativo
De Out 2024 até Out 2024
Renalytix (NASDAQ:RNLX)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024